Investors appear bullish, or is it toadish, on psychedelics, pumping $100M into U.K. firm

Growth op

Beckley Psytech will finish its trial with low-dose psilocybin in patients with a rare and debilitating headache condition, initiate a dose-ranging study on an intranasal treatment and start a Phase 2 trial for treatment-resistant depression.

Excerpt only …
READ MORE BELOW
Source : Investors appear bullish, or is it toadish, on psychedelics, pumping 0M into U.K. firm

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.